1. Home
  2. OSW vs MLYS Comparison

OSW vs MLYS Comparison

Compare OSW & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpaWorld Holdings Limited

OSW

OneSpaWorld Holdings Limited

N/A

Current Price

$22.70

Market Cap

2.7B

ML Signal

N/A

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$23.73

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSW
MLYS
Founded
2017
2019
Country
Bahamas
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
OSW
MLYS
Price
$22.70
$23.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
10
Target Price
$31.20
★ $48.50
AVG Volume (30 Days)
791.6K
★ 1.2M
Earning Date
10-28-2026
11-09-2026
Dividend Yield
★ 0.89%
N/A
EPS Growth
N/A
★ 37.43
EPS
★ 0.44
N/A
Revenue
★ $961,001,000.00
N/A
Revenue This Year
$7.61
N/A
Revenue Next Year
$8.69
N/A
P/E Ratio
$52.08
★ N/A
Revenue Growth
★ 7.37
N/A
52 Week Low
$19.06
$22.30
52 Week High
$29.25
$47.65

Technical Indicators

Market Signals
Indicator
OSW
MLYS
Relative Strength Index (RSI) 42.43 41.01
Support Level $20.95 $22.36
Resistance Level $23.55 $31.19
Average True Range (ATR) 0.59 1.37
MACD 0.21 -0.43
Stochastic Oscillator 50.71 15.65

Price Performance

Historical Comparison
OSW
MLYS

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: